Stability, Toxicity, and Antibacterial Potential of Gallic Acid-Loaded Graphene Oxide (GAGO) Against Methicillin-Resistant Staphylococcus aureus (MRSA) Strains
Suhaili Shamsi,Ahmad Ashraful Hadi Abdul Ghafor,Nur Hazwani Norjoshukrudin,Ida May Jen Ng,Siti Nur Sharmila Abdullah,Seri Narti Edayu Sarchio,Faizah Md Yasin,Shafinaz Abd Gani,Mohd Nasir Mohd Desa
DOI: https://doi.org/10.2147/IJN.S369373
IF: 7.033
2022-12-01
International Journal of Nanomedicine
Abstract:Suhaili Shamsi, 1 Ahmad Ashraful Hadi Abdul Ghafor, 2 Nur Hazwani Norjoshukrudin, 1 Ida May Jen Ng, 1 Siti Nur Sharmila Abdullah, 1 Seri Narti Edayu Sarchio, 2 Faizah Md Yasin, 3, 4 Shafinaz Abd Gani, 1 Mohd Nasir Mohd Desa 2 1 Laboratory of Animal Biochemistry and Biotechnology, Department of Biochemistry, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang, Selangor, 43400, Malaysia; 2 Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, 43400, Malaysia; 3 Department of Chemical and Environmental Engineering, Faculty of Engineering, Universiti Putra Malaysia, Serdang, Selangor, 43400, Malaysia; 4 Institute of Nanoscience and Nanotechnology (ION2), Universiti Putra Malaysia, Serdang, Selangor, 43400, Malaysia Correspondence: Suhaili Shamsi, Laboratory of Animal Biochemistry and Biotechnology, Department of Biochemistry, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang, Selangor, 43400, Malaysia, Tel +603-9769 7964, Fax +603-9769 7590, Email Background: The impetuous usage of antibiotics has led to the perpetual rise of methicillin-resistant Staphylococcus aureus (MRSA), which has garnered the interest of potential drug alternatives, including nanomaterials. Purpose: The present study investigates the stability, toxicity, and antibacterial potential of gallic acid-loaded graphene oxide (GAGO) on several MRSA strains. Methods: The stability of a synthesized and characterized GAGO was monitored in different physiological media. The toxicity profile of GAGO was evaluated in 3T3 murine fibroblast cells and the embryonic zebrafish model. The antibacterial activity of GAGO against MRSA, methicillin-susceptible S. aureus (MSSA), and community-acquired MRSA; with or without Panton-valentine leucocidin gene (MRSA- pvl + and MRSA- pvl- ) was investigated through disk diffusion, CFU counting method, time-kill experiment, and high-resolution transmission electron microscopy (HRTEM) observation. Results: A stable GAGO nanocomposite has shown an improved toxicity profile in 3T3 murine fibroblast cells and zebrafish embryos, besides exhibiting normal ROS levels than graphene oxide (GO) and GA (gallic acid). The nanocomposite inhibited the growth of all bacterial strains employed. The effectiveness of the GAGO nanocomposite was comparable to cefoxitin (CFX), at ≥ 150 μg/mL in MRSA and MSSA. GAGO exhibited a significantly delayed response towards MRSA- pvl + and MRSA- pvl- , with increased inhibition following 8 to 24 h of exposure, while comparable activity to native GA was only achieved at 24 h. Meanwhile, for MRSA and MSSA, GAGO had a comparable activity with native GA and GO as early as 2 h of exposure. HRTEM observation further reveals that GAGO-exposed cells were membrane compromised. Conclusion: In summary, the present study indicates the antibacterial potential of GAGO against MRSA strains, but further study is warranted to understand the mechanism of action of GAGO and its resistance in MRSA strains. Keywords: graphene oxide, gallic acid, nanomaterial, MRSA, toxicity, multidrug resistance Staphylococcus aureus ( S. aureus ) is commonly found on the skin as a normal human microbiota. It does not become pathological until it enters the human body, which causes potent infections leading to a wide range of clinical conditions. 1 Unfortunately, the rampant treatment of antibiotics and other antibacterial therapies have enabled S. aureus to evolve and acquire the multidrug-resistant (MDR) trait, known as methicillin-resistant S. aureus (MRSA). This potentially causes complications in clinical conditions, rendering them harder to treat. 2 MRSA has been listed as one of the seven pathogens of international concern by the World Health Organization (WHO) since 2014. It has caused major concern due to its association with high mortality and septic shock cases worldwide. 3 The national prevalence rate of MRSA in Malaysia ranged from 17.2% to 28.1% between 2016 and 2017, 4 and at present, vancomycin has been used as the ultimate drug for treating MRSA infections. 5 However, there are reports on the resistance of MRSA towards vancomycin in many parts of the world, 6 including the neighboring country, Indonesia. 7 Despite the limited data on vancomycin resistance of MRSA in Malaysia, researchers believed that this strain could also be detected here in the near future. This has raised an ala -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology